FDA expands approval of Instylla’s Embrace HES for arterial bleeds
The US FDA has cleared an expanded indication for Instylla’s Embrace HES to treat peripheral arterial bleeds in vessels measuring up to 6mm.
The post FDA expands approval of Instylla’s Embrace HES for arterial bleeds appeared first on Medical Device Network .